Unknown

Dataset Information

0

Recent advances in managing axial spondyloarthritis.


ABSTRACT: Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that predominantly affects the axial skeleton. The advent of biologic drugs has transformed the management of patients with axSpA. However, non-steroidal anti-inflammatory drugs remain the first-line drug treatment for axSpA. The optimal management of patients with axSpA requires a combination of pharmacological and non-pharmacological treatment modalities, namely exercise and physical therapy. This review looks at novel therapeutic options in patients with axSpA. It also summarises current evidence regarding radiographic progression and treat-to-target in axSpA.

SUBMITTER: Agrawal P 

PROVIDER: S-EPMC7359748 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6549293 | BioStudies
1000-01-01 | S-EPMC5617559 | BioStudies
2019-01-01 | S-EPMC6518358 | BioStudies
1000-01-01 | S-EPMC5833172 | BioStudies
2015-01-01 | S-EPMC4632151 | BioStudies
2020-01-01 | S-EPMC7311492 | BioStudies
2019-01-01 | S-EPMC6514020 | BioStudies
1000-01-01 | S-EPMC6117894 | BioStudies
2017-01-01 | S-EPMC5518107 | BioStudies
2019-01-01 | S-EPMC6735817 | BioStudies